EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Folic acid prescription practice for high-risk prevention of spina bifida at a tertiary care hospital in Addis Ababa, Ethiopia

Bethelehem Yesehak, Amanda Dorsey, Kibruyisfaw Zewdie, Vijaya Kancherla, Yordanos Ashagre

Journal of Pediatric Rehabilitation Medicine · 2023

DOI: 10.3233/prm-230046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Rehabilitation Medicine, 2023. Verfasst von Bethelehem Yesehak und 4 weiteren Autor:innen. Beteiligte Einrichtung: Addis Ababa University, Addis Ababa, Ethiopia. Hauptthemen laut MEDLINE: Folic Acid, Spinal Dysraphism. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Mothers who have had a pregnancy affected by spina bifida are advised to take 4-5 mg/day folic acid pills to prevent recurrence. The folic acid prescription pattern was examined for high-risk mothers whose children received spina bifida surgery in an urban Ethiopian hospital. METHODS: Data were analyzed from a large Ethiopian urban tertiary care hospital that provided spina bifida care. General practitioners recorded 5 mg/day folic acid prescriptions administered to mothers of infants with spina bifida born between January 2019 and June 2022. RESULTS: Among 500 baby-mother pairs, 340 (68%) received a 120-day prescription for 5 mg/day folic acid pills. Of these 340 mothers, 331 (97%) received their folic acid prescription at their child’s first or second patient encounter. Almost all mothers (94%) had documentation of only one prescription for the study duration. The percentage of mothers receiving at least one prescription varied by the baby’s year of birth (2019:75%; 2020:92%; 2021:46%; Jan 2022 –June 2022:79%). CONCLUSION: This prioritization of spina bifida recurrence prevention demonstrates feasibility for other healthcare centers in low-income countries. Sustained funds to provide women with free folic acid pills can favor high compliance and uptake of this prevention intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Folic AcidSpinal DysraphismPregnancyInfantChildFemaleHumansEthiopiaTertiary Care Centers

Stichwörter der Autor:innen

Neural tube defectscongenital anomaliesfolic acidhigh risk preventionspina bifida

Substanzen

Folic Acid

Autor:innen und Institutionen

  • Addis Ababa University, Addis Ababa, Ethiopia.
  • Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA, USA.
  • Zewditu Memorial Hospital, Addis Ababa, Ethiopia.

Zitieren

APA

Yesehak, B., Dorsey, A., Zewdie, K., Kancherla, V., & Ashagre, Y. (2023). Folic acid prescription practice for high-risk prevention of spina bifida at a tertiary care hospital in Addis Ababa, Ethiopia. Journal of Pediatric Rehabilitation Medicine. https://doi.org/10.3233/prm-230046

Vancouver

Yesehak B, Dorsey A, Zewdie K, Kancherla V, Ashagre Y. Folic acid prescription practice for high-risk prevention of spina bifida at a tertiary care hospital in Addis Ababa, Ethiopia. Journal of Pediatric Rehabilitation Medicine. 2023. doi:10.3233/prm-230046

BibTeX
@article{Yesehak2023,
  author = {Yesehak, Bethelehem and Dorsey, Amanda and Zewdie, Kibruyisfaw and Kancherla, Vijaya and Ashagre, Yordanos},
  title = {Folic acid prescription practice for high-risk prevention of spina bifida at a tertiary care hospital in Addis Ababa, Ethiopia},
  journal = {Journal of Pediatric Rehabilitation Medicine},
  year = {2023},
  doi = {10.3233/prm-230046}
}
Kostenlos starten →